Evidence map›Paper›PMID 42304336›Full record

ArticleBMC surgery2026

Predicting PPOI secondary to laparoscopic radical resection of rectal cancer combined with lobaplatin hyperthermic intraperitoneal chemotherapy: a multi-center study.

Wei Zhang, Baitong Che, Nan Yang, Feifei Cheng, Qun Xu, Yaxun Li, Jinkun Xie, Chongshi Gao, Zhiyong Yang, Donglin Ma and 3 more

Abstract readMulticenter Study
In one paragraph

Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wei Zhang *Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, Henan, 471023, P. R. China.
Baitong Che *Jinzhou Central Hospital, Jinzhou, Liaoning, 121000, P. R. China.
Nan YangDepartment of General Surgery, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei, 441000, P. R. China.
Feifei ChengDepartment of General Surgery, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei, 441000, P. R. China.
Qun XuThe First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, 121001, P. R. China.
Yaxun LiThe First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, 121001, P. R. China.
Jinkun XieJinzhou Medical University, Jinzhou, Liaoning, 121001, P. R. China.
Chongshi GaoJinzhou Medical University, Jinzhou, Liaoning, 121001, P. R. China.
Zhiyong YangJinzhou Medical University, Jinzhou, Liaoning, 121001, P. R. China.
Donglin MaJinzhou Medical University, Jinzhou, Liaoning, 121001, P. R. China.
Tianxiao ZhangJinzhou Medical University, Jinzhou, Liaoning, 121001, P. R. China.
Zewen BaJinzhou Medical University, Jinzhou, Liaoning, 121001, P. R. China.
Weibin ZhangJinzhou Central Hospital, Jinzhou, Liaoning, 121000, P. R. China. webean_zhang@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePPOI is one of the common complications of intraperitoneal hyperthermic chemotherapy during laparoscopic radical resection of rectal cancer, which seriously affects the prognosis of patients. The purpose of this study is to establish a prediction system for PPOI secondary to laparoscopic radical resection of rectal cancer combined with intraperitoneal hyperthermic chemotherapy with lobaplatin. MATERIALS AND

methodsRetrospectively analyzed the clinical data of 800 patients who received laparoscopic radical rectal cancer combined with lobaplatin hyperthermia and intraperitoneal chemotherapy in three Level 3 Grade A hospitals from June 1, 2014, to June 1, 2024, and determined the predictive factors through univariate, multivariate, and Lasso regression analysis. We employ eight ML algorithms, Logistic Regression (LR), Decision Tree (DT), Random Forest (RF), Extreme gradient boosting (XGB), Support Vector Machine (SVM), Multilayer Perceptron (MLP), K-Nearest Neighbor (KNN), Gaussian Naive Bayes (GNB), to train and develop ML models using a 10x cross-validation method. The performance of the model was evaluated by a variety of indicators, including the area under the receiver operating characteristic curve (ROC), calibration curve, decision curve, PR curve, and confusion matrix. In addition, model interpretation is performed through Shapley Additive Interpretation (SHAP) analysis to clarify the importance of each feature of the model and its basis for decision-making.

resultsWe identified six key predictors, including Surgical bleeding, Duration of surgery, HB, WBC, ALB and adhesiolysis, and built a prediction model based on these factors. The sensitivity, specificity, positive predictive value, and negative predictive value of different models were compared. All eight models showed good predictive performance and stability, with the RF model being the optimal model. Finally, we developed a web-based calculator based on the optimal model.

conclusionsThese predictors and models were able to assess the potential for PPOI following laparoscopic radical curative rectal cancer combined with lobaplatin hyperthermic intraperitoneal chemotherapy. Early alerts can be provided in a clinical setting, helping medical professionals make informed judgments and select the most appropriate treatment strategy (https://zw17786325639.shinyapps.io/ppoi/).

Indexed as

Antineoplastic AgentsCyclobutanesHyperthermic Intraperitoneal ChemotherapyLaparoscopyOrganoplatinum CompoundsPostoperative ComplicationsRectal NeoplasmsAgedFemaleHumansMaleMiddle AgedPrediction AlgorithmsPredictive Learning ModelsRandom ForestRetrospective StudiesAntineoplastic AgentsCyclobutaneslobaplatinOrganoplatinum CompoundsHyperthermic intraperitoneal chemotherapyLoboplatinMachine learningPredictive modelingProlonged postoperative ileusRectal cancer

Identifiers

PMID42304336
PMCPMC13508199

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.